A study of endoscopic observations of early gastric cancer at three weeks after vonoprazan following endoscopic therapy

A study of endoscopic observations of early gastric cancer at three weeks after vonoprazan following endoscopic therapy - A study of endoscopic observations of early gastric cancer at three weeks after vonoprazan following endoscopic therapy

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000051117

Enrollment

Registered

2023-05-22

Start date

2023-05-22

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

early gastric cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Endoscopic treatment indications

Exclusion criteria

Exclusion criteria: Patients over 90 years of age, patients unable to give consent, other patients considered inappropriate for treatment, and patients with contraindications to vonoprazan.

Design outcomes

Primary

Measure	Time frame
esophagogastroduodenoscopy three weeks after endoscopic treatment to evaluate the size of post-endoscopic ulcer, evaluation of ulcer according to the Sakita-Miwa classification.	—

Countries

Japan

Contacts

Public ContactDaisuke Suto

International University of Health and Welfare Hospital Department of Gastroenterology

daisuto@iuhw.ac.jp0287-39-3060

Outcome results